NCT07473011

Brief Summary

Many spa patients report falling asleep more easily, experiencing fewer nighttime awakenings, and feeling more refreshed upon waking after their treatment. However, these effects have never been formally evaluated in a scientific study. The aim of this study is therefore to measure precisely the impact of the spa treatment on the severity of insomnia. The study does not modify usual care. Participants follow their prescribed spa treatment as planned. They are simply asked to complete questionnaires:

  • before the start of the treatment
  • at the end of the 18-day program
  • and 2 months later The main questionnaire assesses the severity of insomnia. Additional questionnaires evaluate sleep quality, fatigue, pain, anxiety, stress, and quality of life.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started May 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
May 2026Mar 2029

First Submitted

Initial submission to the registry

February 26, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

March 16, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

February 26, 2026

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index

    This instrument assesses the severity and consequences of insomnia through 5 questions. Each item is rated on a five-point Likert scale ranging from 0 to 4. Higher total scores indicate greater insomnia severity (0-7: no insomnia; 8-14: subthreshold insomnia; 15-21: moderate insomnia; 22-28: severe insomnia).

    At baseline (Day 0), and Day 18 (end of treatment)

Secondary Outcomes (13)

  • Nighttime sleep duration

    At baseline (Day 0), Day 18 (end of treatment), and 2 months after completion of treatment

  • Number of nocturnal awakenings

    At baseline (Day 0), Day 18 (end of treatment), and 2 months after completion of treatment.

  • Sleep satisfaction

    At baseline (Day 0), Day 18 (end of treatment), and 2 months after completion of treatment.

  • Pain Assessment Scale

    At baseline (Day 0), Day 18 (end of treatment), and 2 months after completion of treatment

  • Hospital Anxiety and Depression Scale

    At baseline (Day 0), Day 18 (end of treatment), and 2 months after completion of treatment

  • +8 more secondary outcomes

Study Arms (1)

Insomia Cohort

Other: Thermal spa treatment

Interventions

The thermal spa center in Balaruc-les-Bains offers 15 different thermal treatments tailored to each patient's specific needs. A structured protocol of four daily treatments over 18 days is established for each patient to ensure appropriate care. These treatments may be adjusted during the course of the spa program without compromising therapeutic objectives. They are divided into two categories according to the temperature of the thermal water used.

Insomia Cohort

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be selected from all patients admitted for a prescribed 18-day thermal spa treatment at Balaruc-les-Bains as part of their usual medical care, regardless of therapeutic orientation (rheumatology, phlebology, or combined orientation). Eligible participants are adults aged 18 to 90 years, affiliated with the French Social Security system or an equivalent healthcare coverage, and presenting symptoms of insomnia defined by an Insomnia Severity Index (ISI) score ≥ 8. Patients will be informed about the study by their thermal spa physician and the spa medical staff. Inclusion will occur after verification of eligibility criteria and signature of a non-opposition form. Individuals with cognitive impairment, inability to complete questionnaires in French, deprivation of liberty, legal guardianship, or medical contraindications to spa treatment will not be included.

You may qualify if:

  • Individuals following an 18-day thermal spa program
  • Signed non-opposition form
  • Affiliation with the French Social Security system or an equivalent healthcare coverage
  • Insomnia Severity Index (ISI) score ≥ 8

You may not qualify if:

  • Individuals deprived of their liberty by law
  • Individuals under legal guardianship or trusteeship
  • Individuals with cognitive impairment
  • Individuals unable to complete written questionnaires in French
  • Uncontrolled cardiovascular disease
  • Active infectious condition
  • Immunocompromised patients
  • Patients with chronic inflammatory rheumatic disease during an active flare
  • Severe general health impairment, including cachexia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 16, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

March 1, 2029

Last Updated

March 16, 2026

Record last verified: 2026-02